Hangai, Sho http://orcid.org/0000-0003-3657-9731
Kawamura, Takeshi
Kimura, Yoshitaka
Chang, Ching-Yun
Hibino, Sana
Yamamoto, Daisuke http://orcid.org/0000-0002-3539-7728
Nakai, Yousuke
Tateishi, Ryosuke
Oshima, Masanobu
Oshima, Hiroko http://orcid.org/0000-0001-6855-4008
Kodama, Tatsuhiko
Moriya, Kyoji
Koike, Kazuhiko
Yanai, Hideyuki http://orcid.org/0000-0002-0115-9000
Taniguchi, Tadatsugu http://orcid.org/0000-0001-5212-090X
Funding for this research was provided by:
Ministry of Education, Culture, Sports, Science and Technology (Scientific Research (A), 20298458, Scientific Research (S) 15638461, Young Scientist 18030848, Research Fellowship for Young Scientists 19J00887)
The Uehara Memorial Foundation and the Takeda Science Foundation
Japan Agency for Medical Research and Development (AMED-PRIME 1005352)
The Naito Foundation
Article History
Received: 21 September 2020
Accepted: 27 May 2021
First Online: 8 July 2021
Competing interests
: A patent is pending regarding this study; the patent applicant is the University of Tokyo. Inventors are T.T., H.Y. and S. Hangai. The anti-TCTP monoclonal antibody is covered in the patent application (Japanese patent application no. 2020-147222). The remaining authors declare no competing interests.